Geneva Partners’s Praxair Inc PX Stock Holding History

Geneva Partners’s Portfolio PX Stock Details PX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-19,668	Closed	-$3.16M	–	91
2018 Q3	$3.16M	Sell	19,668 -2,605	-12%	-$418K	2.43%	12
2018 Q2	$3.52M	Buy	22,273 +463	+2%	+$71.5K	2.79%	13
2018 Q1	$3.15M	Buy	21,810 +425	+2%	+$66.1K	2.59%	12
2017 Q4	$3.31M	Buy	21,385 +4,785	+29%	+$710K	2.47%	10
2017 Q3	$2.32M	Buy	+16,600	New	+$2.21M	1.83%	16

Other funds holding PX

SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return

OCM

One Capital Management Westlake Village, California $3.6B AUM 16.02% 1-Year Est. Return

CAM

Covenant Asset Management Chester, New Jersey $595M AUM 38.14% 1-Year Est. Return

AWM

Alterna Wealth Management Houston, Texas $174M AUM 15.45% 1-Year Est. Return

GFP

Gryphon Financial Partners Columbus, Ohio $1.13B AUM 30.28% 1-Year Est. Return

Claro Advisors Boston, Massachusetts $953M AUM 24.79% 1-Year Est. Return

Geneva Partners's PX Position: Q4 2018 in Review

Geneva Partners sold out of Praxair Inc (PX) in Q4 2018, closing a stake of 19,668 shares — an estimated $3.16M sold.

Geneva Partners first reported a position in PX in Q3 2017 and held it in 5 quarters. The position peaked at $3.52M in Q2 2018. 6 funds tracked by Wall St. Rank hold PX as of Q4 2018.

Geneva Partners reported no remaining Praxair Inc position as of Q4 2018 after selling out during the quarter.
Geneva Partners sold 19,668 Praxair Inc shares in Q4 2018, an estimated $3.16M.
Geneva Partners first reported a position in Praxair Inc in Q3 2017 and held it in 5 quarters.
Geneva Partners's Praxair Inc position peaked at $3.52M in Q2 2018.
6 funds tracked by Wall St. Rank held Praxair Inc as of Q4 2018.

Based on Geneva Partners's 13F filing for Q4 2018, filed 30 Jan 2019.